Absorbable permeability-modulated barrier composites and applications thereof
Absorbable barrier composites are designed for modulated gas and water permeability depending on clinical use and are formed of at least two physicochemically distinct components, one of which is a film adjoined to a knitted mesh and/or electrostatically spun, non-woven fabric. Depending on the physicochemical properties of the barrier composite, it can be used in neurological and urinogenital surgical procedures as well as tissue engineering and/or as physical barriers to prevent adhesion formation following several types of surgical procedures.
1. An absorbable, permeability-modulated barrier composite comprising, a first component, a component comprising a knitted mesh, and a component comprising an electrostatically spun, non-woven microfibrous fabric;
wherein the first component comprises a flexible film comprising a synthetic absorbable polymer comprising
a) a polyaxial copolyester derived from at least two monomers of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione;
b) a polyether ester derived from a polyether-glycol that is grafted with at least one monomer of glycolide, lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione; or
c) a polyether-ester-urethane derived from a polyether-glycol that is grafted with at least one monomer of glycolide, lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione, to form a polyether ester glycol, where the polyether ester glycol is interconnected by urethane linkages formed through the reaction of said polyether ester glycol with an aliphatic diisocyanate;
wherein the knitted mesh component comprises
a) an absorbable block copolymer comprising a block derived only from trimethylene carbonate and terminal segments derived from glycolide; or
b) a warp-knitted construction comprising a polyaxial copolyester derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, and a morpholinedione; and
wherein the electrostatically spun, non-woven microfibrous fabric component comprises,
a) a polyaxial copolyester derived from at least two monomers of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, or a morpholinedione; or
b) a polyether-ester derived from a polyether-glycol grafted with at least one monomer of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, or a morpholinedione;
wherein the flexible film is adjoined directly to the component comprising the knitted mesh, and the component comprising the knitted mesh is adjoined directly to the component comprising the electrostatically spun, non-woven microfibrous fabric, to form a layered composite;
and optionally, wherein at least one of the components comprises a hydroswellable polymer.
2. The absorbable, permeability-modulated barrier composite as in claim 1 , wherein at least one of the components comprises at least one bioactive agent, wherein the at least one bioactive agent comprises antimicrobial agents, anesthetic agents, anti-inflammatory agents, or tissue growth-promoting agents.
3. The absorbable, permeability-modulated barrier composite as in claim 1 , wherein the flexible film has a thickness of less than 500 microns.
4. The absorbable, permeability-modulated barrier composite as in claim 1 , wherein the flexible film has a thickness of less than 200 microns.
5. The absorbable, permeability-modulated barrier composite as in claim 1 , wherein
the flexible film comprises a polyaxial copolyester derived from at least two monomers of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione; and at least one of the following:
a) the knitted mesh comprises a warp-knitted construction comprising a polyaxial copolyester derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, and a morpholinedione;
b) the microfibrous fabric comprises a polyether-ester derived from a polyether-glycol grafted with derived from at least one monomer of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, or a morpholinedione.
6. The absorbable, permeability-modulated barrier composite as in claim 1 , wherein at least one of the components further comprises at least one bioactive agent.
7. A method of performing a spinal or cranial procedure in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 1 as a dura mater prosthesis in the spinal or cranial area of the subject.
8. A method of preventing surgical adhesions in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 1 in the area of the subject where the surgery was performed.
9. A method for repair, replacement or tissue engineering of components of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin of a vertebrate animal, the method comprising providing an absorbable, permeability- modulated barrier composite of claim 1 to a vertebrate animal for repair, replacement or as a component of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin.
10. A method for repairing or tissue engineering one or more specific sites in the gastrointestinal tract, blood vessels, urinogenital tract, or urinary bladder of a vertebrate animal, the method comprising applying an absorbable, permeability- modulated barrier composite of claim 1 as a patch to the one or more sites in the gastrointestinal tract, blood vessels, urinogenital tract, or the urinary bladder of the vertebrate animal.
11. A method of performing a spinal or cranial procedure in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 5 as a dura mater prosthesis in the spinal or cranial area of the subject.
12. A method of preventing surgical adhesions in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 6 in the area of the subject where surgery was performed.
13. A method for repair, replacement or tissue engineering of components of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin of a vertebrate animal, the method comprising providing an absorbable, permeability-modulated barrier composite of claim 6 to a vertebrate animal for repair, replacement or as a component of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin.
14. A method for repairing or tissue engineering one or more specific sites in the gastrointestinal tract, blood vessels, urinogenital tract, or urinary bladder of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 6 as a patch to the one or more sites in the gastrointestinal tract, blood vessels, urinogenital tract, or the urinary bladder of the vertebrate animal.
15. A method of performing a surgical procedure or reducing surgical adhesions in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 7 in the area of the subject where the surgical procedure was performed.
16. A method for repair, replacement or tissue engineering of components of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin of a vertebrate animal, the method comprising providing an absorbable, permeability- modulated barrier composite of claim 7 to a vertebrate animal for repair, replacement or as a component of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin.
17. A method for repairing or tissue engineering one or more specific sites in the gastrointestinal tract, blood vessels, urinogenital tract, or urinary bladder of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 7 as a patch to the one or more sites in the gastrointestinal tract, blood vessels, urinogenital tract, or the urinary bladder of the vertebrate animal.
18. An absorbable, permeability-modulated barrier composite comprising, a first component, a component comprising a knitted mesh, and a component comprising an electrostatically spun, non-woven microfibrous fabric;
wherein the first component comprises a flexible film comprising a synthetic absorbable polymer comprising
a) a polyaxial copolyester derived from at least two monomers of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione;
b) a polyether ester derived from a polyether-glycol that is grafted with at least one monomer of glycolide, lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione; or
c) a polyether-ester-urethane derived from a polyether-glycol that is grafted with at least one monomer of glycolide, lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1 , 5 -dioxepan- 2 -one or a morpholinedione, to form a polyether ester glycol, where the polyether ester glycol is interconnected by urethane linkages formed through the reaction of said polyether ester glycol with an aliphatic diisocyanate;
wherein the knitted mesh component comprises
a) an absorbable block copolymer comprising a block derived only from trimethylene carbonate and terminal segments derived from glycolide; or
b) a warp-knitted construction comprising a polyaxial copolyester derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, and a morpholinedione; and
wherein the electrostatically spun, non-woven microfibrous fabric component comprises,
a) a polyaxial copolyester derived from at least two monomers of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, or a morpholinedione; or
b) a polyether-ester derived from a polyether-glycol grafted with at least one monomer of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, or a morpholinedione;
wherein the flexible film is adjoined directly to the knitted mesh and the microfibrous fabric is adjoined directly to the knitted mesh, such that the flexible film and the microfibrous fabric are indirectly joined to each other with the knitted mesh sandwiched there between;
and optionally, wherein at least one of the components comprises a hydroswellable polymer.
19. The absorbable, permeability-modulated barrier composite as in claim 18 , wherein at least one of the components comprises at least one bioactive agent, wherein the at least one bioactive agent comprises antimicrobial agents, anesthetic agents, anti-inflammatory agents, or tissue growth-promoting agents.
20. The absorbable, permeability-modulated barrier composite as in claim 18 , wherein the flexible film has a thickness of less than 500 microns.
21. The absorbable, permeability-modulated barrier composite as in claim 18 , wherein the flexible film has a thickness of less than 200 microns.
22. The absorbable, permeability-modulated barrier composite as in claim 18 , wherein
the flexible film comprises a polyaxial copolyester derived from at least two monomers of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione; and at least one of the following:
a) the knitted mesh comprises a warp-knitted construction comprising a polyaxial copolyester derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, and a morpholinedione;
b) the microfibrous fabric comprises a polyether-ester derived from a polyether-glycol grafted with derived from at least one monomer of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, or a morpholinedione.
23. The absorbable, permeability-modulated barrier composite as in claim 18 , wherein at least one of the components further comprises at least one bioactive agent.
24. A method of performing a spinal or cranial procedure in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 18 as a dura mater prosthesis in the spinal or cranial area of the subject.
25. A method of preventing surgical adhesions in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 18 in the area of the subject where the surgery was performed.
26. A method for repair, replacement or tissue engineering of components of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin of a vertebrate animal, the method comprising providing an absorbable, permeability-modulated barrier composite of claim 18 to a vertebrate animal for repair, replacement or as a component of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin.
27. A method for repairing or tissue engineering one or more specific sites in the gastrointestinal tract, blood vessels, urinogenital tract, or urinary bladder of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 18 as a patch to the one or more sites in the gastrointestinal tract, blood vessels, urinogenital tract, or the urinary bladder of the vertebrate animal.
28. A method of performing a spinal or cranial procedure in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 22 as a dura mater prosthesis in the spinal or cranial area of the subject.
29. A method of preventing surgical adhesions in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 23 in the area of the subject where surgery was performed.
30. A method for repair, replacement or tissue engineering of components of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin of a vertebrate animal, the method comprising providing an absorbable, permeability-modulated barrier composite of claim 23 to a vertebrate animal for repair, replacement or as a component of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin.
31. A method for repairing or tissue engineering one or more specific sites in the gastrointestinal tract, blood vessels, urinogenital tract, or urinary bladder of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 23 as a patch to the one or more sites in the gastrointestinal tract, blood vessels, urinogenital tract, or the urinary bladder of the vertebrate animal.
32. A method of performing a surgical procedure or reducing surgical adhesions in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 24 in the area of the subject where the surgical procedure was performed.
33. A method for repair, replacement or tissue engineering of components of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin of a vertebrate animal, the method comprising providing an absorbable, permeability-modulated barrier composite of claim 24 to a vertebrate animal for repair, replacement or as a component of the digestive tract, respiratory system, neurological tissues, bone, cartilage, urinary tract, genital tract, vascular system and skin.
34. A method for repairing or tissue engineering one or more specific sites in the gastrointestinal tract, blood vessels, urinogenital tract, or urinary bladder of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 24 as a patch to the one or more sites in the gastrointestinal tract, blood vessels, urinogenital tract, or the urinary bladder of the vertebrate animal.